A hypothesis-based approach to species identification in the fossil record: a papionin case study by Marianne F. Brasil, Marianne F. Brasil, Tesla A. Monson, Dominic J. Stratford, Dominic J. Stratford, Leslea J. Hlusko, Leslea J. Hlusko

“…Modern papionin monkeys are a diverse group that encompasses a broad range of morphologies, behaviors, and ecologies. …”
Get full text

Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy by Patrizia Murer, Barbara Brannetti, Jean-Michel Rondeau, Laetitia Petersen, Nicole Egli, Simone Popp, Catherine Regnier, Kirsten Richter, Andreas Katopodis, Christoph Huber

“…ANV419 also enhances the NK cell killing capacity and increases tumor growth inhibition when used alongside trastuzumab in a Her-2+ xenograft mouse model. In cynomolgus monkeys, the estimated half-life of ANV419 is 24 h, and doses that induced sustained expansion of effector cells were well tolerated without the severe toxicities typically observed with high-dose IL-2. …”
Get full text

Utilisation des systèmes de test ALDM dans le cadre de l'étude des réseaux sociaux du babouin de Guinée by Julie Gullstrand, Joël Fagot, Nicolas Claldière

“…Le dispositif ALDM (Automated Learning Device for Monkeys) est un réseau de systèmes de conditionnement opérant, mis en libre accès, à la disposition d'un groupe de babouins de Guinée ("Papio papio") hébergé sur la plateforme Cognition Comparée du Primate (CCDP- site de la station de primatologie de Rousset). …”
Get full text

Safety and tolerability of the M2 muscarinic acetylcholine receptor modulator BAY 2413555 in heart failure with reduced ejection fraction in the REMOTE-HF study by Marat Fudim, Muhammad Shahzeb Khan, Dominik Linz, JoAnn Lindenfeld, Calum MacRae, Nina Kimmeskamp-Kirschbaum, Michaela Meyer, Thomas Mondritzki, Hanna Tinel, Wilfried Dinh, Robert J. Mentz

“…The study was terminated early based on new and unexpected preclinical findings from a chronic animal toxicology study in monkeys in which evidence of increased vascular inflammation was observed, leading to a no longer favorable risk-benefit balance for the intended long-term (i.e., life-long) treatment of heart failure patients. …”
Get full text